From: Molecular mechanisms behind progressing chronic inflammatory dilated cardiomyopathy
Variable | Inflammation negative group | Inflammation positive group | Â | ||
---|---|---|---|---|---|
Total No. of pts. | Value | Total No. of pts. | Value | p Value | |
Markers of inflammation in serum | Â | Â | Â | Â | Â |
 TNF-α (pg/mL) | 8 | 7.9313 ± 0.5106 | 21 | 14.2819 ± 5.0280 | 0.223 |
 IL-6 (pg/mL) | 8 | 3.3938 ± 0.8554 | 21 | 11.4038 ± 3.3614 | 0.031* |
 IL-1β (pg/mL) | 8 | 5.0000 ± 0.0000 | 21 | 4.7619 ± 0.2381 | 0.329 |
 CRP (μg/mL) | 8 | 7.6875 ± 5.0460 | 19 | 21.5563 ± 6.9633 | 0.066¡ |
Markers of apoptosis in serum | Â | Â | Â | Â | Â |
 Bcl2 (ng/mg protein) | 10 | 0.0288 ± 0.0288 | 22 | 0.0536 ± 0.0455 | 0.889¡ |
 Bax (ng/mg protein) | 10 | 2.152717 ± 0.24 | 22 | 2.3354 ± 0.1606 | 0.535 |
 Caspase-9 (ng/mg protein) | 10 | 0.012955 ± 0.0013 | 22 | 0.0808 ± 0.0283 | 0.038* |
 Caspase-8 (ng/mg protein) | 10 | 0.001 ± 0.0001 | 22 | 0.0031 ± 0.0009 | 0.043*¡ |
 Caspase-3 (ng/mg protein) | 10 | 0.0029 ± 0.0022 | 22 | 0.0105 ± 0.0023 | 0.025* |
 APO1/Fas/CD95 (ng/mg protein) | 10 | 0.0000 ± 0.0000 | 22 | 0.00004 ± 0.00004 | 0.857¡ |
 FasL (ng/mg protein) | 10 | 0.0000 ± 0.0000 | 22 | 0.0000 ± 0.0000 | N.A. |
 HSP60 (ng/mg protein) | 10 | 0.0419 ± 0.0253 | 22 | 0.3760 ± 0.1468 | 0.035* |
Markers of apoptosis in biopsy | Â | Â | Â | Â | Â |
 Bcl2 (ng/mg protein) | 10 | 83.5523 ± 26.2936 | 21 | 63.8790 ± 17.2137 | 0.540 |
 Bax (ng/mg protein) | 10 | 5.6452 ± 2.6905 | 21 | 6.8873 ± 3.7924 | 0.724¡ |
 Caspase-9 (ng/mg protein) | 10 | 29.6575 ± 12.5969 | 21 | 38.7122 ± 9.6108 | 0.950¡ |
 Caspase-8 (ng/mg protein) | 10 | 0.9483 ± 0.1640 | 21 | 1.1611 ± 0.1962 | 0.413 |
 Caspase-3 (ng/mg protein) | 10 | 0.2503 ± 0.0773 | 21 | 0.2586 ± 0.0649 | 0.935 |
 APO1/Fas/CD95 (ng/mg protein) | 10 | 3.4651 ± 0.6568 | 21 | 4.1921 ± 0.6607 | 0.443 |
 FasL (ng/mg protein) | 10 | 4.5550 ± 1.3594 | 21 | 4.0588 ± 1.1083 | 0.780 |
 HSP-60 (ng/mg protein) | 10 | 24.1262 ± 6.9102 | 21 | 19.2656 ± 4.5617 | 0.565 |
Marker of heart tissue contraction in serum | Â | Â | Â | Â | Â |
 hsTnT (pg/mL) | 8 | 35.4988 ± 9.0908 | 20 | 66.4145 ± 26.9755 | 0.289 |
Markers of extracellular matrix degradation in serum | Â | Â | Â | Â | Â |
 MMP9 (ng/mg protein) | 10 | 1.3867 ± 0.0674 | 22 | 1.5261 ± 0.0508 | 0.115 |
 TIMP1 (ng/mg protein) | 10 | 5.9610 ± 0.3597 | 22 | 6.1223 ± 0.1497 | 0.686 |
 MMP9/TIMP1 | 10 | 0.2355 ± 0.0090 | 22 | 0.2511 ± 0.0086 | 0.223 |
Markers of extracellular matrix degradation in biopsy | Â | Â | Â | Â | Â |
 MMP9 (ng/mg protein) | 10 | 2.3698 ± 1.1931 | 21 | 2.7630 ± 0.9394 | 0.798 |
 TIMP1 (ng/mg protein) | 10 | 9.4917 ± 1.7605 | 21 | 7.8056 ± 1.4029 | 0.462 |
 MMP9/TIMP1 | 10 | 0.1931 ± 0.0729 | 21 | 0.4760 ± 0.1048 | 0.035* |
 Frequency of viral genome | 5 | 50% | 11 | 50% |  |
 BNP (pg/mL) | 10 | 1277.8500 ± 428.5054 | 22 | 1603.2591 ± 276.3777 | 0.532 |